BioMarin Pharmaceutical Inc. buy Wolfe Research
Start price
15.07.25
/
50%
€49.93
Target price
15.07.26
€81.42
Performance (%)
2.62%
End price
16.07.26
€51.24
Summary
This prediction ended on 16.07.26 with a price of €51.24. The BUY prediction by Wolfe_Research finished with a performance of 2.62%. Wolfe_Research has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 2.356% | 2.356% | 5.452% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by Wolfe_Research for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was given a new $95.00 price target on by analysts at Wolfe Research. They now have an "outperform" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten
Current prediction by Wolfe_Research for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.46
16.03.26
16.03.26
-
16.03.27
16.03.27
5.03%
27.07.26
27.07.26
Stopped prediction by Wolfe_Research for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€60.78
15.11.24
15.11.24
€89.95
15.11.25
15.11.25
-22.26%
16.11.25
16.11.25